-
New Hope for Pediatric Patients: FDA Approves Linzess for Functional Constipation
NASDAQ: $IRWD A Significant Milestone for Pediatric Digestive Health Managing digestive health in children can be a challenging experience for both parents and medical providers. Recently, the FDA reached a significant milestone in pediatric care by approving the use of Linzess (linaclotide) for the treatment of functional constipation (FC) in patients aged two years and…